These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21304609)

  • 1. Teratogenic effect of the water extract of bitter gourd (Momordica charantia) on the Sprague Dawley rats.
    Uche-Nwachi EO; McEwen C
    Afr J Tradit Complement Altern Med; 2009 Oct; 7(1):24-33. PubMed ID: 21304609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.
    Sun K; Ding M; Fu C; Li P; Li T; Fang L; Xu J; Zhao Y
    J Ethnopharmacol; 2023 Apr; 306():116154. PubMed ID: 36634725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo hypoglycemic effect of methanolic fruit extract of Momordica charantia L.
    Nkambo W; Anyama NG; Onegi B
    Afr Health Sci; 2013 Dec; 13(4):933-9. PubMed ID: 24940315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihyperglycemic effects of three extracts from Momordica charantia.
    Virdi J; Sivakami S; Shahani S; Suthar AC; Banavalikar MM; Biyani MK
    J Ethnopharmacol; 2003 Sep; 88(1):107-11. PubMed ID: 12902059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bitter gourd (Momordica charantia) possess developmental toxicity as revealed by screening the seeds and fruit extracts in zebrafish embryos.
    Khan MF; Abutaha N; Nasr FA; Alqahtani AS; Noman OM; Wadaan MAM
    BMC Complement Altern Med; 2019 Jul; 19(1):184. PubMed ID: 31340810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia).
    Mahwish ; Saeed F; Arshad MS; Nisa MU; Nadeem MT; Arshad MU
    Lipids Health Dis; 2017 Nov; 16(1):211. PubMed ID: 29126447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alcoholic extract of Momordica charantia (Linn.) whole fruit powder on the pancreatic islets of alloxan diabetic albino rats.
    Singh N; Gupta M; Sirohi P; Varsha
    J Environ Biol; 2008 Jan; 29(1):101-6. PubMed ID: 18831340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats.
    Shetty AK; Kumar GS; Sambaiah K; Salimath PV
    Plant Foods Hum Nutr; 2005 Sep; 60(3):109-12. PubMed ID: 16187012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.
    Krawinkel MB; Keding GB
    Nutr Rev; 2006 Jul; 64(7 Pt 1):331-7. PubMed ID: 16910221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities.
    Yibchok-anun S; Adisakwattana S; Yao CY; Sangvanich P; Roengsumran S; Hsu WH
    Biol Pharm Bull; 2006 Jun; 29(6):1126-31. PubMed ID: 16755004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive activity of the fruit of Momordica charantia with exercise on blood glucose in type 2 diabetic mice.
    Miura T; Itoh Y; Iwamoto N; Kato M; Ishida T
    Biol Pharm Bull; 2004 Feb; 27(2):248-50. PubMed ID: 14758046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Momordica charantia on pancreatic histopathological changes associated with streptozotocin-induced diabetes in neonatal rats.
    Abdollahi M; Zuki AB; Goh YM; Rezaeizadeh A; Noordin MM
    Histol Histopathol; 2011 Jan; 26(1):13-21. PubMed ID: 21117023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Momordica charantia and type 2 diabetes: from in vitro to human studies.
    Habicht SD; Ludwig C; Yang RY; Krawinkel MB
    Curr Diabetes Rev; 2014 Jan; 10(1):48-60. PubMed ID: 24295371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of pancreatic β-cells in neonatally streptozotocin-induced type 2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp.
    Hafizur RM; Kabir N; Chishti S
    Nat Prod Res; 2011 Feb; 25(4):353-67. PubMed ID: 21328131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiulcer activity of methanolic extract of Momordica charantia L. in rats.
    Alam S; Asad M; Asdaq SM; Prasad VS
    J Ethnopharmacol; 2009 Jun; 123(3):464-9. PubMed ID: 19501279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Momordica charantia for type 2 diabetes mellitus.
    Ooi CP; Yassin Z; Hamid TA
    Cochrane Database Syst Rev; 2012 Aug; (8):CD007845. PubMed ID: 22895968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats.
    Abd El Sattar El Batran S; El-Gengaihi SE; El Shabrawy OA
    J Ethnopharmacol; 2006 Nov; 108(2):236-42. PubMed ID: 16815658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological changes in the kidneys of experimental diabetic rats fed with Momordica charantia (bitter gourd) extract.
    Teoh SL; Abd Latiff A; Das S
    Rom J Morphol Embryol; 2010; 51(1):91-5. PubMed ID: 20191126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Momordica charantia ointment accelerates diabetic wound healing and enhances transforming growth factor-β expression.
    Hussan F; Teoh SL; Muhamad N; Mazlan M; Latiff AA
    J Wound Care; 2014 Aug; 23(8):400, 402, 404-7. PubMed ID: 25139598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
    Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
    Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.